On the chart for the last 30 days, the fluctuation of ANI Pharmaceuticals (ANIP) stock with the high volatility at $32.93 is illustrated. The highest price of the stock was $34.56 on July 12 and the lowest one was $31.00 on July 30. The market cap of ANI Pharmaceuticals is $419.525 million.
On August 6, the financial results for the second quarter were announced. According to the results, The net revenue is $48.6 million while the net loss is $14.1 million. The Adjusted Non-GAAP EBITDA is $13.1 million and Adjusted Non-GAAP diluted earnings for every share is $0.67.
One of the business highlights for the second quarter is that the company has refilled the application for the Cortrophin Gel with the U.S FDA (Food And Drug Administration). Also, the company obtained Novitium Pharma LLC. For the portfolio of dermatology products, ANI purchased new drug applications from Sandoz Inc.